Downregulated expression of inhibitor of growth 4 (ING4) in advanced colorectal cancers: a non-randomized

Qi You1, Xi-Shan Wang, Song-Bin Fu

  • 1Department of Colorectal Surgery, The Tumor Hospital of Harbin Medical University, Harbin, People's Republic of China.

Insights

Early detection of colorectal cancer improves outcomes. Our study found that ING4 gene expression is reduced in colorectal tumors and linked to advanced disease stages and metastasis, suggesting its role in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) has a high cure rate when detected early.
  • Identifying genes involved in CRC can aid early diagnosis and reduce mortality.
  • The role of ING4 in colorectal carcinoma progression requires further investigation.

Purpose of the Study:

  • To investigate the correlation between ING4 gene expression and pathological features in colorectal cancer patients.
  • To assess the potential of ING4 as a biomarker for colorectal cancer diagnosis and prognosis.

Main Methods:

  • Assayed ING4 protein expression levels in tumor samples from 97 colorectal cancer patients.
  • Analyzed ING4 expression in relation to adenoma, normal mucosa, and colorectal cancer tissues.
  • Correlated ING4 expression with Dukes' stages and lymphatic metastasis.

Main Results:

  • ING4 protein expression was downregulated in adenoma compared to normal mucosa.
  • ING4 expression was further reduced in colorectal cancer tissues.
  • Suppressed ING4 expression correlated with advanced Dukes' stages and lymphatic metastasis.

Conclusions:

  • ING4 downregulation is associated with colorectal cancer progression.
  • ING4 may play a significant role in the development and advancement of colorectal carcinoma.
  • Further research into ING4's function could lead to novel diagnostic and therapeutic strategies.